NCT04561076View on ClinicalTrials.gov

Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 9, 2020

Primary Completion Date

September 6, 2021

Study Completion Date

September 18, 2021

Conditions
COVID 19
Interventions
DRUG

HLX70

Single-dose, intravenous infusion

OTHER

Placebo

Single-dose, intravenous infusion

Sponsors
All Listed Sponsors
collaborator

Sanyou Biopharmaceuticals(Shanghai)Co., Ltd

UNKNOWN

collaborator

Shanghai ZJ Bio-Tech Co., Ltd

UNKNOWN

lead

Hengenix Biotech Inc

INDUSTRY